Proven achievements in the pharmaceutical drug development lifecycle: from early process development to process validation to process commercialization to continuous process improvements. This includes both (a) therapeutics areas such as hematology, oncology, ophthalmology, and pulmonology; and (b) therapeutic modalities such as small molecules (peptides), and large molecules (antibody-drug conjugates [ADCs], monoclonal antibodies [mAbs], PEGylated peptides, and polymers). Demonstrated experience in selecting, implementing, managing, and decommissioning global contract manufacturing organizations (CMOs).Direct and equitable leader who mobilizes and empowers staff with the courage to develop and achieve individual goals in alignment with organizational mission, vision, and values. This includes having staff challenge the “we have always done it this way” mentality. Visionary leader with a unique blend of executive competencies: strategic Technical Operations (TO) planning, defining and implementing functional and operational requirements, and identifying and evaluating the feasibility for greater efficiency.